These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 17092602

  • 21. [A case of malignant pleural mesothelioma that responded to cisplatin plus pemetrexed rechallenge].
    Shukuya T, Takahashi T, Nakamura Y, Yamamoto N.
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):487-90. PubMed ID: 20332689
    [Abstract] [Full Text] [Related]

  • 22. Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.
    Zucali PA, Simonelli M, Michetti G, Tiseo M, Ceresoli GL, Collovà E, Follador A, Lo Dico M, Moretti A, De Vincenzo F, Lorenzi E, Perrino M, Giordano L, Farina G, Santoro A, Garassino M.
    Lung Cancer; 2012 Mar; 75(3):360-7. PubMed ID: 21937142
    [Abstract] [Full Text] [Related]

  • 23. A retrospective study of chemotherapy with and without pemetrexed in malignant pleural mesothelioma.
    Higashiguchi M, Suzuki H, Hirashima T, Kobayashi M, Goya S, Okamoto N, Matsuura Y, Tamiya M, Morishita N, Tsumori T, Kawase I.
    Anticancer Res; 2012 Feb; 32(2):609-13. PubMed ID: 22287752
    [Abstract] [Full Text] [Related]

  • 24. Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program.
    Taylor P, Castagneto B, Dark G, Marangolo M, Scagliotti GV, van Klaveren RJ, Labianca R, Serke M, Schuette W, van Meerbeeck JP, Heigener D, Liu Y, Adachi S, Blatter J, von Pawel J.
    J Thorac Oncol; 2008 Jul; 3(7):764-71. PubMed ID: 18594323
    [Abstract] [Full Text] [Related]

  • 25. Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.
    Jassem J, Ramlau R, Santoro A, Schuette W, Chemaissani A, Hong S, Blatter J, Adachi S, Hanauske A, Manegold C.
    J Clin Oncol; 2008 Apr 01; 26(10):1698-704. PubMed ID: 18375898
    [Abstract] [Full Text] [Related]

  • 26. Safety and effectiveness of pemetrexed in patients with malignant pleural mesothelioma based on all-case drug-registry study.
    Kuribayashi K, Voss S, Nishiuma S, Arakawa K, Nogi Y, Mikami K, Kudoh S.
    Lung Cancer; 2012 Mar 01; 75(3):353-9. PubMed ID: 21890228
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma].
    Wang YY, Zhang H, Bai H, Wang SH, Wu MN, An TT, Zhao J, Zhuo ML, Duan JC, Wang ZJ, Wang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar 01; 36(3):162-8. PubMed ID: 23856136
    [Abstract] [Full Text] [Related]

  • 31. Nursing considerations for administering pemetrexed (Alimta) in combination with cisplatin for malignant pleural mesothelioma.
    Orbaugh KK.
    Clin J Oncol Nurs; 2004 Jun 01; 8(3):242-7. PubMed ID: 15208818
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Update of pemetrexed in thoracic oncology].
    Brechot JM, Morère JF.
    Bull Cancer; 2007 Jun 01; 94 Spec No Actualites():S139-41. PubMed ID: 17845984
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.
    Yamanaka T, Tanaka F, Hasegawa S, Okada M, Soejima T, Kamikonya N, Fukuoka K, Nakano T.
    Jpn J Clin Oncol; 2009 Mar 01; 39(3):186-8. PubMed ID: 19131427
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma.
    Berghmans T, Lafitte JJ, Paesmans M, Stach B, Berchier MC, Wackenier P, Lecomte J, Collon T, Mommen P, Sculier JP, European Lung Cancer Working Party (ELCWP).
    Lung Cancer; 2005 Oct 01; 50(1):75-82. PubMed ID: 16005104
    [Abstract] [Full Text] [Related]

  • 39. Pemetrexed (Alimta): improving outcomes in malignant pleural mesothelioma.
    Budde LS, Hanna NH.
    Expert Rev Anticancer Ther; 2004 Jun 01; 4(3):361-8. PubMed ID: 15161435
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.